In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 5, 1999, Pages 641-645

  Giacometti, A ^a   Cirioni, O ^b   Barchiesi, F ^b   Fortuna, M ^b   Scalise, G ^b  

^a Azienda Ospedaliera Umberto I   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CECROPIN; CEFTAZIDIME; CLARITHROMYCIN; COLISTIN; DOXYCYCLINE; MAGAININ 2; MEROPENEM; NETILMICIN; NISIN; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; MINIMUM INHIBITORY CONCENTRATION; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, MICROBIAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; MICROBIAL SENSITIVITY TESTS; NISIN; PEPTIDES; PEPTIDES, CYCLIC; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; XENOPUS PROTEINS;

EID: 0032739820     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.5.641     Document Type: Article

References (24)

1. Mouton, J. W., den Hollander J. G. & Horrevorts A. M. (1993). Emergence of antibiotic resistance amongst Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Journal of Antimicrobial Chemotherapy 31, 919-26.
2. Masuda N. & Ohya S. (1992). Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 36, 1847-51.
3. Margaret, B. S., Drusano, G. L. & Standiford H. C. (1989). Emergence of resistance to carbapenem antibiotics in Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 161-7.
4. den Hollander, J. G, Horrevorts, A. M., van Goor, M. L. P. J., Verbrugh, H. A. & Mouton, J. W. (1997). Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model. Antimicrobial Agents and Chemotherapy 41, 95-100.
5. Giacometti, A., Cirioni, O., Greganti, G., Quarta, M. & Scalise, G. (1998). In vitro activities of membrane-active peptides against Gram-positive and Gram-negative aerobic bacteria. Antimicrobial Agents and Chemotherapy 42, 3320-4.
6. Livermore, D. M. & Chen, H. Y. (1997). Potentiation of β-lactams against Pseudomonas aeruginosa strains by Ro 48-1256, a bridged monobactam inhibitor of AmpC β-lactamases. Journal of Antimicrobial Chemotherapy 40, 335-43.
7. Hall, L. M., Livermore, D. M., Gur, D., Akova, M. & Akalin H. E. (1993). OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 37, 1637-44.
8. Bevins, C. L. & Zasloff, M. (1990). Peptides from frog skin. Annual Review of Biochemistry 59, 395-414.
9. Clark, D. P., Durell, S., Maloy, W. L. & Zasloff, M. (1994). Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catasbeiana) skin, structurally related to the bacterial antibiotic, polymyxin. Journal of Biological Chemistry 269, 10849-55.
10. Jack, R. W., Tagg, J. R. & Ray, B. (1995). Bacteriocins of Gram-positive bacteria. Microbiological Review 59, 171-200.
11. Moore, A. J., Beazley, W. D., Bibby, M. C. & Devine, D. A. (1996). Antimicrobial activity of cecropins. Journal of Antimicrobial Chemotherapy 37, 1077-89.
12. Sahl, H. G., Jack, R. W. & Bierbaum, G. (1995). Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. European Journal of Biochemistry 230, 827-53.
13. Severina, E., Severin, A. & Tomasz, A. (1998). Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens. Journal of Antimicrobial Chemotherapy 41, 341-7.
14. Falla, T. J. & Hancock, R. E. W. (1997). Improved activity of a synthetic indolicidin analog. Antimicrobial Agents and Chemotherapy 41, 771-5.
15. Hancock, R. E. (1997). Antibacterial peptides and the outer membranes of Gram-negative bacilli. Journal of Medical Microbiology 46, 1-3.
16. Vaara, M. & Porro, M. (1996). Group of peptides that act synergistically with hydrophobic antibiotics against Gram-negative enteric bacteria. Antimicrobial Agents and Chemotherapy 40, 1801-5.
17. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically - Third Edition: Approved Standard M7-A3. NCCLS, Villanova, PA.
18. Hindler, J. (1992). Tests to assess bactericidal activity. In Clinical Microbiology Procedures Handbook, (Eisenberg, H. D., Ed.), p. 5, 14, 16-24. American Society for Microbiology, Washington, DC.
19. Falla, T. J., Karunaratne, D. N. & Hancock, R. E. W. (1996). Mode of action of the antimicrobial peptide indolicidin. Journal of Biological Chemistry 271, 19298-303.
20. Piers, K. L. & Hancock, R. E. W. (1994). The interaction of a recombinant cecropin/mellitin hybrid peptide with the outer membrane of Pseudomonas aeruginosa. Molecular Microbiology 12, 951-8.
21. Zasloff, M. (1987). Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proceedings of the National Academy of Science of the United States of America 84, 5449-53.
22. Viljanen, P., Matsunaga, H., Kimura, Y. & Vaara, M. (1991). The outer membrane permeability-increasing action of deacylpolymyxins. Journal of Antibiotics 44, 517-23.
23. Howe, R. A. & Spencer, R. C. (1997). Macrolides for the treatment of Pseudomonas aeruginosa infections? Journal of Antimicrobial Chemotherapy 40, 153-5.
24. Tateda, K., Ishii, Y., Matsumoto, T., Furuya, N., Ohno, A., Miyazaki, S. et al. (1996). New evidence of anti-pseudomonal activity of macrolides. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, 1996. Abstract C82, p. 49. American Society for Microbiology, Washington, DC.